Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$1.66M
49.40K shares
What this filing means
PHILLIPS ANDREW JOHN plans to sell 49.40K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $1.66M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001950047-26-003102
Director
Since Feb 2023
49.40K
Shares to sell
$1.66M
Approx. market value
26.04K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/31/2026
26.04KTotal acquired26.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2026 | Stock Option Exercise Cash | 26.04K | — |
| Total | 26.04K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
21.84K
Market value
$611.7K
2/2/2026
—Completed
Units to sell
1.52K
Market value
$42.6K
1/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
26.04K
Market value
$1.00M
3/31/2026
Total
Units
49.40K
Value
$1.66M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 21.84K | $611.7K | — | Completed |
1/22/2026 | 1.52K | $42.6K | — | Completed |
| Planned — Approximate Date | ||||
3/31/2026 | 26.04K | $1.00M | NASDAQ | Planned |
| Total | 49.40K | $1.66M | ||